Literature DB >> 27378462

Intensive lowering of blood pressure: Should we SPRINT?

Doreen M Rabi1, Raj Padwal2.   

Abstract

Mesh:

Substances:

Year:  2016        PMID: 27378462      PMCID: PMC5056865          DOI: 10.1503/cmaj.160147

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  11 in total

1.  Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.

Authors:  Alberto Zanchetti; Lisheng Liu; Giuseppe Mancia; Gianfranco Parati; Guido Grassi; Marco Stramba-Badiale; Vincenzo Silani; Grzegorz Bilo; Giovanni Corrao; Antonella Zambon; Lorenza Scotti; Xinhua Zhang; Ting Rui Guan; Yuqing Zhang; Xuezhong Zhang; Eivind Berge; Josep Redon; Krzysztof Narkiewicz; Anna Dominiczak; Peter Nilsson; Margus Viigimaa; Stéphane Laurent; Enrico Agabiti-Rosei; Zhaosu Wu; Dingliang Zhu; José Luis Rodicio; Luis Miguel Ruilope; Nieves Martell-Claros; Fernando Pinto; Roland E Schmieder; Michel Burnier; Maciej Banach; Renata Cifkova; Csaba Farsang; Alexandra Konradi; Irina Lazareva; Yuriy Sirenko; Maria Dorobantu; Arman Postadzhiyan; Rok Accetto; Bojan Jelakovic; Dragan Lovic; Athanasios J Manolis; Philippos Stylianou; Dror Dicker; Gangzhi Wei; Chengbin Xu; Hengge Xie; Antonio Coca; John O'Brien; Gary Ford
Journal:  J Hypertens       Date:  2016-03       Impact factor: 4.844

Review 2.  The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Authors:  Stella S Daskalopoulou; Doreen M Rabi; Kelly B Zarnke; Kaberi Dasgupta; Kara Nerenberg; Lyne Cloutier; Mark Gelfer; Maxime Lamarre-Cliche; Alain Milot; Peter Bolli; Donald W McKay; Guy Tremblay; Donna McLean; Sheldon W Tobe; Marcel Ruzicka; Kevin D Burns; Michel Vallée; G V Ramesh Prasad; Marcel Lebel; Ross D Feldman; Peter Selby; Andrew Pipe; Ernesto L Schiffrin; Philip A McFarlane; Paul Oh; Robert A Hegele; Milan Khara; Thomas W Wilson; S Brian Penner; Ellen Burgess; Robert J Herman; Simon L Bacon; Simon W Rabkin; Richard E Gilbert; Tavis S Campbell; Steven Grover; George Honos; Patrice Lindsay; Michael D Hill; Shelagh B Coutts; Gord Gubitz; Norman R C Campbell; Gordon W Moe; Jonathan G Howlett; Jean-Martin Boulanger; Ally Prebtani; Pierre Larochelle; Lawrence A Leiter; Charlotte Jones; Richard I Ogilvie; Vincent Woo; Janusz Kaczorowski; Luc Trudeau; Robert J Petrella; Swapnil Hiremath; James A Stone; Denis Drouin; Kim L Lavoie; Pavel Hamet; George Fodor; Jean C Grégoire; Anne Fournier; Richard Lewanczuk; George K Dresser; Mukul Sharma; Debra Reid; Geneviève Benoit; Janusz Feber; Kevin C Harris; Luc Poirier; Raj S Padwal
Journal:  Can J Cardiol       Date:  2015-05       Impact factor: 5.223

Review 3.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

4.  Effects of intensive blood-pressure control in type 2 diabetes mellitus.

Authors:  William C Cushman; Gregory W Evans; Robert P Byington; David C Goff; Richard H Grimm; Jeffrey A Cutler; Denise G Simons-Morton; Jan N Basile; Marshall A Corson; Jeffrey L Probstfield; Lois Katz; Kevin A Peterson; William T Friedewald; John B Buse; J Thomas Bigger; Hertzel C Gerstein; Faramarz Ismail-Beigi
Journal:  N Engl J Med       Date:  2010-03-14       Impact factor: 91.245

5.  Blood pressure control in the Hypertension in the Very Elderly Trial (HYVET).

Authors:  C J Bulpitt; N S Beckett; R Peters; G Leonetti; V Gergova; R Fagard; L A Burch; W Banya; A E Fletcher
Journal:  J Hum Hypertens       Date:  2011-03-10       Impact factor: 3.012

6.  A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

Authors:  Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius
Journal:  N Engl J Med       Date:  2015-11-09       Impact factor: 91.245

7.  Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data.

Authors: 
Journal:  Lancet       Date:  2014-08-16       Impact factor: 79.321

8.  Identifying Individuals at Risk for Cardiovascular Events Across the Spectrum of Blood Pressure Levels.

Authors:  Kunal N Karmali; Hongyan Ning; David C Goff; Donald M Lloyd-Jones
Journal:  J Am Heart Assoc       Date:  2015-09-21       Impact factor: 5.501

Review 9.  Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis.

Authors:  Xinfang Xie; Emily Atkins; Jicheng Lv; Alexander Bennett; Bruce Neal; Toshiharu Ninomiya; Mark Woodward; Stephen MacMahon; Fiona Turnbull; Graham S Hillis; John Chalmers; Jonathan Mant; Abdul Salam; Kazem Rahimi; Vlado Perkovic; Anthony Rodgers
Journal:  Lancet       Date:  2015-11-07       Impact factor: 79.321

10.  Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial.

Authors:  Karen L Margolis; Patrick J O'Connor; Timothy M Morgan; John B Buse; Robert M Cohen; William C Cushman; Jeffrey A Cutler; Gregory W Evans; Hertzel C Gerstein; Richard H Grimm; Edward W Lipkin; K M Venkat Narayan; Matthew C Riddle; Ajay Sood; David C Goff
Journal:  Diabetes Care       Date:  2014-03-04       Impact factor: 19.112

View more
  2 in total

1.  Is it premature to SPRINT?

Authors:  David M Allen
Journal:  CMAJ       Date:  2017-02-06       Impact factor: 8.262

2.  Canadian Cardiovascular Harmonized National Guidelines Endeavour (C-CHANGE) guideline for the prevention and management of cardiovascular disease in primary care: 2018 update.

Authors:  Sheldon W Tobe; James A Stone; Todd Anderson; Simon Bacon; Alice Y Y Cheng; Stella S Daskalopoulou; Justin A Ezekowitz; Jean C Gregoire; Gord Gubitz; Rahul Jain; Karim Keshavjee; Patty Lindsay; Mary L'Abbe; David C W Lau; Lawrence A Leiter; Eileen O'Meara; Glen J Pearson; Doreen M Rabi; Diana Sherifali; Peter Selby; Jack V Tu; Sean Wharton; Kimberly M Walker; Diane Hua-Stewart; Peter P Liu
Journal:  CMAJ       Date:  2018-10-09       Impact factor: 8.262

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.